⌘K

Login Start Free

Home/Filings/4/0001209191-11-026696

4//SEC Filing

Engler Robert 4

Accession 0001209191-11-026696

CIK 0001159036other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:13 PM ET

Size

10.8 KB

Accession

0001209191-11-026696

Insider Transaction Report

Form 4

Period: 2011-05-05

HALOZYME THERAPEUTICS INCHALO

Director

Transactions

Award
Common Stock
2011-05-05$0.00/sh+20,000$20→ 125,000 total

Footnotes (1)

[F1]Shares acquired as compensation for services pursuant to Halozyme Therapeutics, Inc. 2008 Outside Directors' Stock Plan.

Documents

2 files

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeother

Related Parties

1

filerCIK 0001078452

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 5:13 PM ET
Size: 10.8 KB

View on SEC.gov